Wordt geladen...
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)
Recently, the standard of care for metastatic Castration Resistant Prostate Cancer (mCRPC) has changed considerably. Persistent androgen receptor (AR) signaling has been identified as a target for novel therapies and reengages the fact that AR continues to be the primary target responsible for metas...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4167156/ https://ncbi.nlm.nih.gov/pubmed/25062956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-14-55 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|